Piper Sandler Trims Aptose Biosciences (NASDAQ:APTO) Target Price to $5.00
Aptose Biosciences (NASDAQ:APTO – Free Report) (TSE:APS) had its target price cut by Piper Sandler from $12.00 to $5.00 in a research note released on Thursday morning, Benzinga reports. They currently have an overweight rating on the biotechnology company’s stock. Several other research analysts have also commented on the stock. StockNews.com raised shares of Aptose […]
More Stories
Vital Energy (NYSE:VTLE) & Diversified Energy (NYSE:DEC) Head to Head Analysis
Vital Energy (NYSE:VTLE – Get Free Report) and Diversified Energy (NYSE:DEC – Get Free Report) are both small-cap oils/energy companies,...
Head-To-Head Comparison: Connectm Technology Solutions (NASDAQ:CNTM) vs. Brookfield Business Partners (NYSE:BBU)
Connectm Technology Solutions (NASDAQ:CNTM – Get Free Report) and Brookfield Business Partners (NYSE:BBU – Get Free Report) are both small-cap...
Secure Energy Services Inc. (TSE:SES) Given Average Rating of “Moderate Buy” by Analysts
Secure Energy Services Inc. (TSE:SES – Get Free Report) has been given an average recommendation of “Moderate Buy” by the...
Contrasting Apple Hospitality REIT (NYSE:APLE) & Plymouth Industrial REIT (NYSE:PLYM)
Apple Hospitality REIT (NYSE:APLE – Get Free Report) and Plymouth Industrial REIT (NYSE:PLYM – Get Free Report) are both finance...
Analysts Set ServiceTitan Inc. (NASDAQ:TTAN) Target Price at $117.00
ServiceTitan Inc. (NASDAQ:TTAN – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the fourteen brokerages...
HIVE Digital Technologies (NASDAQ:HIVE) vs. Crescent Capital BDC (NASDAQ:CCAP) Financial Survey
Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) and HIVE Digital Technologies (NASDAQ:HIVE – Get Free Report) are both small-cap...